India is one of the few large markets where primary dental care is still reaching new consumers; global companies that provide devices and consumables for Indian dentists have found a fertile market. Here in Southern California where I live, Brea-based Envista Holdings is expanding its presence in India with the launch of its Kerr dental consumables business, as the dental products company that owns Kerr, Ormco, and Nobel Biocare seeks to diversify its revenue base.
The company announced on September 1 that Kerr products will now be introduced more broadly in India, with an initial focus on restorative and endodontic dentistry. Kerr, a longstanding dental brand within Envista’s portfolio, produces materials and other consumables used by dentists in restorative procedures and root canal treatment. For Envista, the move reflects the increasing importance of India within its international growth strategy. The country has a large base of dental professionals, while demand for higher-quality restorative and aesthetic dentistry is increasing as incomes rise, private dental practices expand and patients become more aware of available treatments.
India’s dental market is also changing beyond the largest metropolitan areas. Private clinics, dental chains and specialty practices have expanded in many Tier 2 and Tier 3 cities, creating a broader potential market for international manufacturers of dental equipment, materials and consumables.
Envista CEO Paul Keel described India as one of the company’s strategic growth markets and pointed to the country’s expanding dental infrastructure and changing clinical practices as reasons for further investment. The company plans to support the Kerr introduction with clinician training, hands-on workshops and continuing education programs. It also expects to work with universities, professional organizations and other industry participants. A multi-city program involving international dental experts is planned following the initial launch.
This approach is significant because selling medical and dental products in India often involves more than establishing distribution. Manufacturers frequently need to invest in clinician education, technical support and relationships with hospitals, universities and professional organizations, particularly when introducing products that compete on clinical performance rather than primarily on price.
Envista also intends to expand Kerr’s reach beyond India’s largest cities. Vikrant Trilokekar, managing director of Envista India and South Asia, said the company plans to combine new product introductions with local service and technical support.
Kerr itself is not a new brand. Founded 135 years ago, it has an established international presence in restorative and endodontic dentistry. Bringing a broader Kerr portfolio into India therefore represents less of a new-market experiment than an extension of Envista’s existing global product strategy into a market it sees as increasingly important.
What that means for medical device companies
For American healthcare companies, Envista’s move is another example of how India is evolving from a market served primarily through limited product distribution into one where multinational companies are investing more deliberately in local market development. As India’s healthcare infrastructure expands beyond its largest cities, companies that can combine international products with local training, service and clinical engagement may find a substantially larger addressable market than was available a decade ago.
